Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisprofol alone versus cisprofol plus fentanyl for sedation during upper gastrointestinal endoscopy
ChiCTR2400088300Phase 3Not yet recruiting
- Sponsor
- Yancheng First People's Hospital
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciprofol and fentanyl in None (2 arms), sponsored by Yancheng First People's Hospital. Primary endpoint: Sedation success rate. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
ciprofolfentanyl
Beyond the preview
Go deeper on ChiCTR2400088300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088300.